Beneficient (BENF) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The company's financial performance is extremely poor, with significant declines in revenue, net income, and EPS. There are no positive trading trends, news catalysts, or signals from Intellectia Proprietary Trading Signals to support a buy decision. Additionally, the lack of valuation data, recent congress trading activity, and analyst ratings further diminish confidence in the stock.

Technical Analysis

The MACD is positive and expanding, suggesting mild bullish momentum. The RSI is neutral at 66.774, and moving averages are converging, indicating no clear trend. The stock closed at $4.59, above the pivot point of $4.169, but below the first resistance level (R1) of $5.005. Overall, the technical indicators are inconclusive and do not strongly support a buy decision.

Positive Catalysts

NULL identified. No recent news, analyst upgrades, or significant trading trends.

Neutral/Negative Catalysts

There is no recent congress trading data or valuation data to provide confidence in the stock. Additionally, the post-market price dropped by -3.35%, indicating weak sentiment.

Financial Performance

In Q3 2026, Beneficient's revenue dropped to $10,000 (-99.78% YoY), net income dropped to $19,913,000 (-330.50% YoY), and EPS dropped to 0 (-100.00% YoY). Gross margin remained at 0, showing no improvement.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for analyst ratings or price target changes.

Analyst Rating

Wall Street analysts forecast BENF stock price to rise

Buy

Hold

Sell

Current: 4.660

Low

Averages

High